Journal of Oncology · 2022 · 44 citations · 24 references
We first construct and validate TGF-<i>β</i> characteristics that can predict immune microenvironment phenotypes and immunotherapeutic effect in multiple datasets. Noteworthy, TGF-<i>β</i> risk score is helpful for individualized precise treatment of patients with the head and neck squamous cell carcinoma.
24
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
McLane J. Watson, Paolo Vignali, Steven J. Mullett et al. · Nature · 2021 · 1.1K citations · Full text
Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco et al. · Journal for ImmunoTherapy of Cancer · 2019 · 712 citations · Full text
Neoadjuvant Therapy, Squamous Cell Carcinoma, Immunology +24
Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer
Richard B. Hayes, Jiyoung Ahn, Xiaozhou Fan et al. · JAMA Oncology · 2018 · 316 citations · Full text